Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novavax Inc (NASDAQ:NVAX)

10.26
Delayed Data
As of Sep 04
 -0.15 / -1.44%
Today’s Change
3.92
Today|||52-Week Range
15.01
+73.02%
Year-to-Date

Today’s Trading

Previous close10.41
Today’s open10.28
Day’s range10.11 - 10.54
Volume3,961,682
Average volume (3 months)4,813,681
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 09/04/2015

Growth & Valuation

Earnings growth (last year)-19.35%
Earnings growth (this year)-4.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+46.59%
P/E ratioNM
Price/Sales43.68
Price/Book10.83

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-1.04-1.66%
KITEKite Pharma Inc+1.84+3.53%
HALOHalozyme Therapeutic...+0.04+0.24%
JUNOJuno Therapeutics In...+1.03+2.95%
Data as of 4:14pm ET, 09/04/2015

Financials

Next reporting dateNovember 6, 2015
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$30.7M
Annual profit (last year)-$82.9M
Net profit margin-270.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts

Partner Offers